Aerska
PrivateLast Round
Series A
Feb 9, 2026
Total Funding Raised
$60M
Momentum Score
25 /100
Company Overview
Aerska is a biotechnology company developing RNA interference (RNAi) medicines designed to treat, delay, and prevent diseases of the brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aerska Comps
Public and private peers based on sector, stage, and business model.
Aerska Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 9, 2026 | ||||
| Seed | Oct 1, 2025 |
Aerska Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iaso Ventures | Series A |
| Backed VC | Seed |
| Saras Capital | Seed |
| Lingotto | Seed |
| BlueYard Capital | Seed |
| Ada Ventures | Seed |
| age1 | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Lisa Taylor Ash joins the Board of Directors.
- Apr 15, 2026
Stuart Milstein appointed to lead AOC platform development.
Aerska Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aerska's valuation, stock price, and market status.